Engineered CD200R antibodies and uses thereof
In some aspects, provided herein are antibodies or antigen-binding fragments that bind to CD200R, a glycoprotein receptor present on cell surfaces. Antibodies or antigen-binding fragments provided herein, in some cases, agonize CD200R signaling pathway that inhibits inflammation and immune response....
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DAVIS, SIMON JOHN MURRAY, LYNNE ANNE SCOTT, ELEANOR MARYSIA TOMAZELA, DANIELA M PALUCH, CHRISTOPHER DOUGLAS CORNALL, RICHARD JOHN ROBERTSON, NATHAN JACOB |
| description | In some aspects, provided herein are antibodies or antigen-binding fragments that bind to CD200R, a glycoprotein receptor present on cell surfaces. Antibodies or antigen-binding fragments provided herein, in some cases, agonize CD200R signaling pathway that inhibits inflammation and immune response. In other aspects, provided herein are compositions, methods of use, methods of making, polynucleotides, vectors, host cells, and kits relating to antibodies or antigen-binding fragments that bind to CD200R. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW202346358A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW202346358A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW202346358A3</originalsourceid><addsrcrecordid>eNrjZNB1zUvPzEtNLUpNUXB2MTIwCFJIzCvJTMpPyUwtBjJTFEqLgYySDKCK_DQeBta0xJziVF4ozc2g6OYa4uyhm1qQH59aXJCYnJqXWhIfEm5kYGRsYmZsauFoTIwaAE3jKU0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Engineered CD200R antibodies and uses thereof</title><source>esp@cenet</source><creator>DAVIS, SIMON JOHN ; MURRAY, LYNNE ANNE ; SCOTT, ELEANOR MARYSIA ; TOMAZELA, DANIELA M ; PALUCH, CHRISTOPHER DOUGLAS ; CORNALL, RICHARD JOHN ; ROBERTSON, NATHAN JACOB</creator><creatorcontrib>DAVIS, SIMON JOHN ; MURRAY, LYNNE ANNE ; SCOTT, ELEANOR MARYSIA ; TOMAZELA, DANIELA M ; PALUCH, CHRISTOPHER DOUGLAS ; CORNALL, RICHARD JOHN ; ROBERTSON, NATHAN JACOB</creatorcontrib><description>In some aspects, provided herein are antibodies or antigen-binding fragments that bind to CD200R, a glycoprotein receptor present on cell surfaces. Antibodies or antigen-binding fragments provided herein, in some cases, agonize CD200R signaling pathway that inhibits inflammation and immune response. In other aspects, provided herein are compositions, methods of use, methods of making, polynucleotides, vectors, host cells, and kits relating to antibodies or antigen-binding fragments that bind to CD200R.</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231201&DB=EPODOC&CC=TW&NR=202346358A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231201&DB=EPODOC&CC=TW&NR=202346358A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DAVIS, SIMON JOHN</creatorcontrib><creatorcontrib>MURRAY, LYNNE ANNE</creatorcontrib><creatorcontrib>SCOTT, ELEANOR MARYSIA</creatorcontrib><creatorcontrib>TOMAZELA, DANIELA M</creatorcontrib><creatorcontrib>PALUCH, CHRISTOPHER DOUGLAS</creatorcontrib><creatorcontrib>CORNALL, RICHARD JOHN</creatorcontrib><creatorcontrib>ROBERTSON, NATHAN JACOB</creatorcontrib><title>Engineered CD200R antibodies and uses thereof</title><description>In some aspects, provided herein are antibodies or antigen-binding fragments that bind to CD200R, a glycoprotein receptor present on cell surfaces. Antibodies or antigen-binding fragments provided herein, in some cases, agonize CD200R signaling pathway that inhibits inflammation and immune response. In other aspects, provided herein are compositions, methods of use, methods of making, polynucleotides, vectors, host cells, and kits relating to antibodies or antigen-binding fragments that bind to CD200R.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB1zUvPzEtNLUpNUXB2MTIwCFJIzCvJTMpPyUwtBjJTFEqLgYySDKCK_DQeBta0xJziVF4ozc2g6OYa4uyhm1qQH59aXJCYnJqXWhIfEm5kYGRsYmZsauFoTIwaAE3jKU0</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>DAVIS, SIMON JOHN</creator><creator>MURRAY, LYNNE ANNE</creator><creator>SCOTT, ELEANOR MARYSIA</creator><creator>TOMAZELA, DANIELA M</creator><creator>PALUCH, CHRISTOPHER DOUGLAS</creator><creator>CORNALL, RICHARD JOHN</creator><creator>ROBERTSON, NATHAN JACOB</creator><scope>EVB</scope></search><sort><creationdate>20231201</creationdate><title>Engineered CD200R antibodies and uses thereof</title><author>DAVIS, SIMON JOHN ; MURRAY, LYNNE ANNE ; SCOTT, ELEANOR MARYSIA ; TOMAZELA, DANIELA M ; PALUCH, CHRISTOPHER DOUGLAS ; CORNALL, RICHARD JOHN ; ROBERTSON, NATHAN JACOB</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW202346358A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>DAVIS, SIMON JOHN</creatorcontrib><creatorcontrib>MURRAY, LYNNE ANNE</creatorcontrib><creatorcontrib>SCOTT, ELEANOR MARYSIA</creatorcontrib><creatorcontrib>TOMAZELA, DANIELA M</creatorcontrib><creatorcontrib>PALUCH, CHRISTOPHER DOUGLAS</creatorcontrib><creatorcontrib>CORNALL, RICHARD JOHN</creatorcontrib><creatorcontrib>ROBERTSON, NATHAN JACOB</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DAVIS, SIMON JOHN</au><au>MURRAY, LYNNE ANNE</au><au>SCOTT, ELEANOR MARYSIA</au><au>TOMAZELA, DANIELA M</au><au>PALUCH, CHRISTOPHER DOUGLAS</au><au>CORNALL, RICHARD JOHN</au><au>ROBERTSON, NATHAN JACOB</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Engineered CD200R antibodies and uses thereof</title><date>2023-12-01</date><risdate>2023</risdate><abstract>In some aspects, provided herein are antibodies or antigen-binding fragments that bind to CD200R, a glycoprotein receptor present on cell surfaces. Antibodies or antigen-binding fragments provided herein, in some cases, agonize CD200R signaling pathway that inhibits inflammation and immune response. In other aspects, provided herein are compositions, methods of use, methods of making, polynucleotides, vectors, host cells, and kits relating to antibodies or antigen-binding fragments that bind to CD200R.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_TW202346358A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | Engineered CD200R antibodies and uses thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T11%3A25%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DAVIS,%20SIMON%20JOHN&rft.date=2023-12-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW202346358A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |